INTC vs LLY: Which Is the Better Buy?
Side-by-side comparison of Intel Corp. and Eli Lilly and Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Intel Corp. · Technology
$127.39
-8.4% upside to fair value
Low Conviction
Grade D
VS
Eli Lilly and Company · Healthcare
$1,183.72
+2.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
LLY has more upside to fair value
(+2.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTC |
LLY |
| Current Price |
$127.39 |
$1,183.72 |
| Fair Value Estimate |
$116.75 |
$1,208.00 |
| Upside to Fair Value |
-8.4%
|
+2.1%
|
| Market Cap |
$642.6B |
$1,114.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
185.2x
|
26.8x
|
| Price / Sales |
11.3x
|
14.0x
|
| Price / FCF |
229.7x
|
52.7x
|
| Revenue Growth YoY |
+25.4%
|
+47.7%
|
| Gross Margin |
38.9%
|
83.4%
|
| Operating Margin |
0.1%
|
49.7%
|
| Return on Equity |
-10.8%
|
92.6%
|
| Dividend Yield |
0% |
0.57% |
| FCF Yield |
0.44%
|
1.9%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Intel designs and manufactures CPUs, GPUs, networking silicon, and edge and data-center products across its Client Computing, Data Center and AI, and Intel Foundry segments, employing roughly 85,100 people under CEO Lip-Bu Tan. The business quality is currently low: TTM gross margin is 38.9%, TTM operating margin is 0.1%, TTM net margin is -19.8%, and ROE is -10.8%, so the company is not earning …
Eli Lilly is a global pharmaceutical company whose incretin franchise, led by Mounjaro and Zepbound, has become the dominant growth engine in diabetes and obesity care. The business quality is high: TTM gross margin is 83.4%, TTM operating margin is 49.7%, TTM net margin is 33.5%, and ROE is 92.6%, while revenue grew 47.7% and earnings grew 25.3% in the most recent quarter on a year-over-year bas…
Accumulation Zones
| Metric |
INTC |
LLY |
| Zone Low |
$87.56 |
$906.00 |
| Zone High |
$99.24 |
$1,026.80 |
| In Buy Zone? |
No
|
No
|